Drug maker AbCellera wins emergency use authorization for COVID treatment.

Real Money's James 'Rev Shark' Deporre looks at where valuations are and who is trading in these markets.

'Lilium won’t generate revenue for a few years. ... But Lilium could fundamentally reshape the transportation industry,' Piper said.

The recent trading environment reminds Real Money's 'Rev Shark' of what was going on in February.

A 0.7% increase in retail sales for August was unable to push the market higher even though analysts had been expecting a decline.

Latest producer price numbers temper concerns the Fed will start tapering soon.

'Many of the macro factors driving overearning by [Avis Budget] in 2021 will likely persist well into 2022,' Bank of America says.

Cisco Systems stock is in the midst of a correction. Here's where support should come into play.

Gap, American Express, Ford, DoorDash and Tuesday Morning are five top stock gainers for Thursday.

From supply chain shortages to big spending in Washington, Wall Street's historically toughest month has a number of additional factors at play this year.